Brown Advisory Inc. Acquires 149 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Posted by Defense World Staff on Aug 17th, 2023

Brown Advisory Inc. raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 7.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,217 shares of the company’s stock after purchasing an additional 149 shares during the period. Brown Advisory Inc.’s holdings in HCA Healthcare were worth $585,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in HCA. HHM Wealth Advisors LLC lifted its holdings in shares of HCA Healthcare by 0.7% during the 1st quarter. HHM Wealth Advisors LLC now owns 5,493 shares of the company’s stock valued at $1,448,000 after buying an additional 39 shares during the period. SouthState Corp raised its holdings in HCA Healthcare by 6.8% in the 1st quarter. SouthState Corp now owns 642 shares of the company’s stock worth $169,000 after purchasing an additional 41 shares during the period. HMS Capital Management LLC raised its holdings in HCA Healthcare by 0.7% in the 1st quarter. HMS Capital Management LLC now owns 6,631 shares of the company’s stock worth $1,748,000 after purchasing an additional 43 shares during the period. Geneos Wealth Management Inc. raised its holdings in HCA Healthcare by 56.4% in the 4th quarter. Geneos Wealth Management Inc. now owns 122 shares of the company’s stock worth $29,000 after purchasing an additional 44 shares during the period. Finally, Highview Capital Management LLC DE raised its holdings in HCA Healthcare by 0.9% in the 1st quarter. Highview Capital Management LLC DE now owns 4,785 shares of the company’s stock worth $1,262,000 after purchasing an additional 44 shares during the period. Hedge funds and other institutional investors own 62.86% of the company’s stock.

HCA Healthcare Price Performance

NYSE HCA opened at $267.12 on Thursday. HCA Healthcare, Inc. has a 12-month low of $178.32 and a 12-month high of $304.86. The stock has a market capitalization of $72.65 billion, a PE ratio of 13.14, a price-to-earnings-growth ratio of 1.40 and a beta of 1.61. The company has a quick ratio of 1.03, a current ratio of 1.20 and a debt-to-equity ratio of 79.26. The company has a 50 day moving average price of $284.34 and a two-hundred day moving average price of $271.36.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Thursday, July 27th. The company reported $4.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.28 by $0.01. HCA Healthcare had a net margin of 9.32% and a negative return on equity of 12,765.76%. The business had revenue of $15.86 billion for the quarter, compared to analyst estimates of $15.63 billion. During the same quarter in the previous year, the firm posted $4.21 earnings per share. HCA Healthcare’s revenue was up 7.0% compared to the same quarter last year. As a group, equities analysts predict that HCA Healthcare, Inc. will post 18.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $2.40 annualized dividend and a yield of 0.90%. HCA Healthcare’s dividend payout ratio is currently 11.81%.

Insider Activity

In other news, SVP Jeffrey E. Cohen sold 1,500 shares of the stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $270.00, for a total value of $405,000.00. Following the completion of the sale, the senior vice president now owns 4,414 shares of the company’s stock, valued at approximately $1,191,780. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other HCA Healthcare news, SVP Jeffrey E. Cohen sold 1,500 shares of the stock in a transaction on Friday, August 11th. The stock was sold at an average price of $270.00, for a total transaction of $405,000.00. Following the transaction, the senior vice president now owns 4,414 shares in the company, valued at approximately $1,191,780. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Kathryn A. Torres sold 5,204 shares of the firm’s stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $269.12, for a total value of $1,400,500.48. Following the completion of the sale, the senior vice president now directly owns 19,760 shares in the company, valued at $5,317,811.20. The disclosure for this sale can be found here. Insiders sold a total of 9,620 shares of company stock valued at $2,592,820 in the last ninety days. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

HCA has been the subject of a number of analyst reports. Wells Fargo & Company increased their price target on HCA Healthcare from $243.00 to $275.00 in a research note on Tuesday, April 25th. Barclays lifted their price target on shares of HCA Healthcare from $275.00 to $300.00 in a report on Wednesday, June 28th. Credit Suisse Group boosted their price objective on shares of HCA Healthcare from $311.00 to $316.00 and gave the company an “outperform” rating in a report on Friday, July 28th. Stephens reiterated an “overweight” rating and issued a $283.00 price objective on shares of HCA Healthcare in a research report on Friday, April 21st. Finally, Cantor Fitzgerald started coverage on shares of HCA Healthcare in a research note on Thursday, April 20th. They set an “overweight” rating and a $304.00 price objective for the company. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $310.36.

Read Our Latest Stock Report on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities.